Hostname: page-component-8448b6f56d-jr42d Total loading time: 0 Render date: 2024-04-23T16:19:06.654Z Has data issue: false hasContentIssue false

A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care

Published online by Cambridge University Press:  17 June 2009

R. Moss-Morris*
Affiliation:
School of Psychology, University of Southampton, UK
L. McAlpine
Affiliation:
ProCare Psychological Services, Auckland, New Zealand
L. P. Didsbury
Affiliation:
ProCare Psychological Services, Auckland, New Zealand
M. J. Spence
Affiliation:
Department of Psychological Medicine, The University of Auckland, Auckland, New Zealand
*
*Address for correspondence: Professor R. Moss-Morris, School of Psychology, University of Southampton, Highfield, SouthamptonSO17 1BJ, UK. (Email: remm@soton.ac.uk)

Abstract

Background

Recent guidelines for the treatment of irritable bowel syndrome (IBS) emphasize the need for research to facilitate home-based self-management for these patients in primary care. The aim of the current study was to test the efficacy of a manualized cognitive behavioural therapy (CBT)-based self-management programme for IBS in a pilot randomized controlled trial (RCT).

Method

Sixty-four primary-care patients meeting Rome criteria for IBS were randomized into either self-management plus treatment as usual (TAU) (n=31) or a TAU control condition (n=33). The self-management condition included a structured 7-week manualized programme that was self-administered in conjunction with a 1-hour face-to-face therapy session and two 1-hour telephone sessions. The primary outcome measures were the Subject's Global Assessment (SGA) of Relief and the Irritable Bowel Syndrome Severity Scoring System (IBS-SSS) assessed at baseline, end of treatment (2 months), and 3 and 6 months post-treatment.

Results

Analysis was by intention-to-treat. Twenty-three (76.7%) of the self-management group rated themselves as experiencing symptom relief across all three time periods compared to seven (21.2%) of the TAU controls [odds ratio (OR) 12.2, 95% confidence interval (CI) 3.72–40.1]. At 8 months, 25 (83%) of the self-management group showed a clinically significant change on the IBS-SSS compared to 16 (49%) of the control group (OR 5.3, 95% CI 1.64–17.26).

Conclusions

This study provides preliminary evidence that CBT-based self-management in the form of a structured manual and minimal therapist contact is an effective and acceptable form of treatment for primary-care IBS patients.

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Akehurst, RL, Brazier, JE, Mathers, N, O'Keefe, C, Kaltenthaler, E, Morgan, A, Platts, M, Walters, SJ (2002). Health-related quality of life and cost of irritable bowel syndrome. Pharmacoeconomics 20, 455462.CrossRefGoogle ScholarPubMed
Blanchard, EB (2001). Irritable Bowel Syndrome: Psychosocial Assessment and Treatment. American Psychological Association: Washington, DC.Google Scholar
Boyce, PM, Koloski, NA, Talley, NJ (2000). Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? American Journal of Gastroenterology 95, 31763183.CrossRefGoogle ScholarPubMed
Boyce, PM, Talley, NJ, Balaam, B, Koloski, NA, Truman, G (2003). A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. American Journal of Gastroenterology 98, 22092218.Google Scholar
Brandt, LJ, Bjorkman, D, Fennerty, MB, Locke, GR, Olden, K, Peterson, W, Quigley, E, Schoenfeld, P, Schuster, M, Talley, N (2002). Systematic review on the management of irritable bowel syndrome in North America. American Journal of Gastroenterology 97, S7–S26.Google ScholarPubMed
Dean, BB, Aguilar, D, Barghout, V, Kahler, KH, Frech, F, Ofman, JJ (2005). Impairment in work productivity and health-related quality of life in patients with IBS. American Journal of Managed Care 11, S17S18.Google ScholarPubMed
Drossman, DA, Toner, BB, Whitehead, WE, Diamant, NE, Dalton, CB, Duncan, S, Emmott, S, Proffitt, V, Akman, D, Frusciante, K, Le, T, Meyer, K, Bradshaw, B, Mikula, K, Morris, CB, Blackman, CJ, Hu, Y, Jia, H, Li, JZ, Koch, GG, Bangdiwala, SI (2003). Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 125, 1931.CrossRefGoogle ScholarPubMed
Ehlin, AGC, Montgomery, SM, Ekbom, A, Pounder, RE, Wakefield, AJ (2006). Prevalence of gastrointestinal diseases in two British national birth cohorts. Gut 52, 11171121.CrossRefGoogle Scholar
Francis, CY, Morris, J, Whorwell, PJ (1997). The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Alimentary Pharmacological Therapy 11, 395402.Google Scholar
Hellier, MD, Sanderson, JD, Morris, AI, Elias, E, De Caestecker, J (2006). Care of Patients with Gastrointestinal Disorders in the United Kingdom: A Strategy for the Future. British Society of Gastroenterology: UK.Google Scholar
Jones, J, Boorman, J, Cann, P, Forbes, A, Gomborone, J, Heaton, K, Hungin, P, Kumar, D, Libby, G, Spiller, R, Read, N, Silk, D, Whorwell, P (2000). British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut 47 (Suppl. 2), ii1ii19.CrossRefGoogle ScholarPubMed
Kennedy, A, Robinson, A, Rogers, A (2003). Incorporating patient's views and experiences of life with IBS in the development of an evidence based self-help guidebook. Patients Education and Counseling 50, 303310.Google Scholar
Kennedy, T, Jones, R, Darnley, S, Seed, P, Wessely, S, Chalder, C (2005). Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. British Medical Journal 331, 435.CrossRefGoogle ScholarPubMed
Kennedy, TM, Chalder, C, McCrone, P, Darnley, S, Knapp, M, Jones, RH, Wessely, S (2006). Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. Health Technology Assessment 10, 167.Google Scholar
Lackner, JM, Mesmer, C, Morley, S, Dowzer, C, Hamilton, S (2004). Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. Journal of Consulting and Clinical Psychology 72, 11001113.CrossRefGoogle ScholarPubMed
Longstreth, GF, Thompson, WG, Chey, WD, Houghton, LA, Mearin, F, Spiller, RC (2006). Functional bowel disorders. Gastroenterology International 130, 14801491.Google Scholar
McCrone, P, Knapp, M, Kennedy, T, Darnley, S, Seed, P, Jones, R, Chalder, C (2008). Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome. Gastroenterology and Hepatology 20, 255263.Google ScholarPubMed
Mearin, F, Badia, X, Balboa, A, Baro, E, Caldwell, E, Cucala, M, Diaz-Rubio, M, Fueyo, A, Ponce, J, Roset, M, Talley, NJ (2001). Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scandinavian Journal of Gastroenterology 36, 11551161.CrossRefGoogle ScholarPubMed
Moss-Morris, R, Spence, M (2006). To ‘lump’ or to ‘split’ the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome? Psychosomatic Medicine 68, 463469.Google Scholar
Muller-Lissner, S, Koch, G, Talley, NJ, Drossman, D, Rueegg, P, Dunger-Baldauf, C, Lefkowitz, M (2003). Subject's Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials. Journal of Clinical Epidemiology 56, 310316.Google Scholar
Mundt, JC, Marks, IM, Shear, MK, Greist, JH (2002). The Work and Social Adjustment Scale: a simple measure of impairment in functioning. British Journal of Psychiatry 180, 461464.Google Scholar
Robinson, A, Lee, V, Kennedy, A, Middleton, L, Rogers, A, Thompson, DG, Reeves, D (2006). A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome. Gut 55, 643648.Google Scholar
Saito, YA, Locke, GR, Talley, NJ, Zinsmeister, AR, Fett, SL, Melton, LJ 3rd (2000). A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. American Journal of Gastroenterology 95, 28162824.CrossRefGoogle ScholarPubMed
Speckens, AEM, van Hemert, AM, Spinhoven, P, Hawton, KE, Bolk, JH, Rooijmans, HGM (1995). Cognitive behavioural therapy for medically unexplained physical symptoms: a randomised controlled trial. British Medical Journal 311, 13281332.Google Scholar
Spence, M, Moss-Morris, R (2007). The cognitive behavioural model of irritable bowel syndrome. Gut 56, 10661071.CrossRefGoogle ScholarPubMed
Thompson, WG (1999). The road to Rome. Gut 45 (Suppl. 2), II80II81.Google Scholar
Thompson, WG, Creed, F, Drossman, DA, Heaton, K, Mazzacca, G (1992). Functional bowel disorders and chronic functional abdominal pain. Gastroenterology International 5, 7591.Google Scholar
Thompson, WG, Heaton, KW, Smyth, GT, Smyth, C (2000). Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 46, 7882.CrossRefGoogle ScholarPubMed
Thompson, WG, Longstreth, GF, Drossman, DA, Heaton, KW, Irvine, EJ, Muller-Lissner, SA (1999). Functional bowel disorders and functional abdominal pain. Gut 45 (Suppl. II), 4347.Google Scholar
Zigmond, AS, Snaith, RP (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica 67, 361370.CrossRefGoogle ScholarPubMed